Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3240982rdf:typepubmed:Citationlld:pubmed
pubmed-article:3240982lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3240982lifeskim:mentionsumls-concept:C0039097lld:lifeskim
pubmed-article:3240982lifeskim:mentionsumls-concept:C0002520lld:lifeskim
pubmed-article:3240982lifeskim:mentionsumls-concept:C0031667lld:lifeskim
pubmed-article:3240982lifeskim:mentionsumls-concept:C0002518lld:lifeskim
pubmed-article:3240982lifeskim:mentionsumls-concept:C0486616lld:lifeskim
pubmed-article:3240982lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:3240982pubmed:issue3lld:pubmed
pubmed-article:3240982pubmed:dateCreated1989-5-19lld:pubmed
pubmed-article:3240982pubmed:abstractTextThe amino acid composition and partial NH2-terminal amino acid sequence of an extracellular phospholipase A2 in human rheumatoid synovial fluid were determined. The predominant amino acids in the phospholipase A2 were cysteine, glycine, arginine, and lysine, suggesting that it is a basic one. The NH2-terminal 34 amino acids were found to be as follows: Asn-Leu-Val-Asn-Phe-His-Arg-Met-Ile-Lys-Leu-Thr-Thr-Gly-Lys-Glu-Ala-Ala-Leu- Ser-Tyr-Gly-Phe-Tyr-Gly-Cys-X-Cys-Gly-Val-Gly-Gly-Arg-Gly The enzyme contains Phe-5, Met-8, Ile-9, Tyr-24, Gly-25, Cys-26, Cys-28, Gly-29, Gly-31, Gly-32, and Gly-34 residues, all of which are conserved in most of the sequenced phospholipase A2. The remarkable feature of this enzyme was the absence of Cys-11, which is conserved in the "Group I" enzyme family. This is the first report concerning partial amino acid sequences of human non-pancreatic phospholipase A2.lld:pubmed
pubmed-article:3240982pubmed:languageenglld:pubmed
pubmed-article:3240982pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3240982pubmed:citationSubsetIMlld:pubmed
pubmed-article:3240982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3240982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3240982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3240982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3240982pubmed:statusMEDLINElld:pubmed
pubmed-article:3240982pubmed:monthSeplld:pubmed
pubmed-article:3240982pubmed:issn0021-924Xlld:pubmed
pubmed-article:3240982pubmed:authorpubmed-author:InoueKKlld:pubmed
pubmed-article:3240982pubmed:authorpubmed-author:HaraSSlld:pubmed
pubmed-article:3240982pubmed:authorpubmed-author:KudoIIlld:pubmed
pubmed-article:3240982pubmed:authorpubmed-author:MiyamotoTTlld:pubmed
pubmed-article:3240982pubmed:authorpubmed-author:MatsutaKKlld:pubmed
pubmed-article:3240982pubmed:issnTypePrintlld:pubmed
pubmed-article:3240982pubmed:volume104lld:pubmed
pubmed-article:3240982pubmed:ownerNLMlld:pubmed
pubmed-article:3240982pubmed:authorsCompleteYlld:pubmed
pubmed-article:3240982pubmed:pagination326-8lld:pubmed
pubmed-article:3240982pubmed:dateRevised2007-12-19lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:meshHeadingpubmed-meshheading:3240982-...lld:pubmed
pubmed-article:3240982pubmed:year1988lld:pubmed
pubmed-article:3240982pubmed:articleTitleAmino acid composition and NH2-terminal amino acid sequence of human phospholipase A2 purified from rheumatoid synovial fluid.lld:pubmed
pubmed-article:3240982pubmed:affiliationDepartment of Health Chemistry, Faculty of Pharmaceutical Sciences, Tokyo.lld:pubmed
pubmed-article:3240982pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3240982pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5320entrezgene:pubmedpubmed-article:3240982lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3240982lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3240982lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3240982lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3240982lld:pubmed